Aidoc Launches AI-Powered Neuroimaging Software for Vessel Occlusion Detection on CT
Full Brain Solution is reportedly the only artificial intelligence (AI)-enabled software that facilitates detection of medium vessel occlusions (MeVOs) as well as anterior and posterior large vessel occlusions (LVOs) on computed tomography (CT) exams.
Ischemic strokes reportedly account for 87 percent of the 795,000 annual strokes that occur in the United States, according to the Centers for Disease Control and Prevention (CDC). Researchers have estimated that medium vessel occlusions (MeVOs) cause between 25 to 40 percent of ischemic strokes and 24 to 46 percent of ischemic strokes are due to large vessel occlusions (LVOs).
With these statistics in mind, Aidoc has launched the Full Brain Solution, an AI-powered software that helps diagnose MeVOs and LVOs on computed tomography (CT) scans.
"AI has shown remarkable success in enhancing workflow for patients with anterior LVOs, nearly halving the time to treatment. However, this is just the beginning. With Aidoc’s Full Brain Solution, we can now broaden these advancements to benefit a significantly larger patient population, leading to improved care and ultimately better outcomes,” noted Brian Mason, M.D., an associate professor of neuroendovascular surgery at the University of Illinois Champaign.
Aidoc has launched the Full Brain Solution, an AI-powered software that helps diagnose medium vessel occlusions (MeVOs) andlarge vessel occlusions (LVOs) on computed tomography (CT) scans. (Images courtesy of Aidoc.)
In addition to aiding the diagnosis of acute ischemic strokes, Aidoc said the Full Brain Solution utilizes AI image-based detection and natural language processing to enhance diagnosis and facilitate subsequent care for patients with brain aneurysms as well as subdural and intracerebral hemorrhages.
(Editor’s note: For related content, see "RapidAI Gets FDA Nod for AI Assessment of Non-Contrast CT for Acute Stroke Triage” and “FDA Clears AI-Powered Stroke Imaging Tool for Non-Contrast CT.”)
FDA Clears Enhanced MRI-Guided Laser Ablation System
June 5th 2025An alternative to an open neurosurgical approach, the Visualase V2 MRI-Guided Laser Ablation System reportedly utilizes laser interstitial thermal therapy (LITT) for targeted soft tissue ablation in patients with brain tumors and focal epilepsy.
Can Abbreviated MRI Have an Impact in Differentiating Intraductal Papilloma and Ductal Secretion?
June 3rd 2025For patients with inconclusive ultrasound results, abbreviated breast MRI offers comparable detection of intraductal papilloma as a full breast MRI protocol at significantly reduced times for scan acquisition and interpretation, according to a new study.
Can AI Assessment of PET Imaging Predict Treatment Outcomes for Patients with Lymphoma?
June 2nd 2025The use of adjunctive AI software with pre-treatment PET imaging demonstrated over a fourfold higher likelihood of predicting progression-free survival (PFS) in patients being treated for lymphoma, according to a new meta-analysis.
